1443460-91-0
Chemical Structure
GSK2838232
- CAS. Nr.: 1443460-91-0
- Formula:C48H73ClN2O6
- Molecular Weight:809.56
IUPAC Name: 4-(((3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-3a-((R)-2-((4-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-1-hydroxyethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2H-cyclopenta[a]chrysen-9-yl)oxy)
InChIKey: MEOWKUXNVNJAMY-PZFKGGKESA-N
SMILES: CC1(C)[C@@H](OC(CC(C)(C)C(O)=O)=O)CC[C@@]2(C)[C@@]1([H])CC[C@]3(C)[C@]2([H])CC[C@@]4([H])[C@@]3(C)CC[C@](C5)([C@H](CN(CCN(C)C)CC6=CC=C(Cl)C=C6)O)C4=C(C(C)C)C5=O
Biological Activity:
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GSK2838232 | 98.99% | GSK2838232 inhibit HIV reverse transcriptase activity across a broad panel of HIV-1 isolates, extracted from patent WO/2013090664A1, compound51. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords